Cargando…

Investigation of N-Acetyltransferase 2-Mediated Drug Interactions of Amifampridine: In Vitro and In Vivo Evidence of Drug Interactions with Acetaminophen

Amifampridine is a drug used for the treatment of Lambert–Eaton myasthenic syndrome (LEMS) and was approved by the Food and Drug Administration (FDA) of the United States (US) in 2018. It is mainly metabolized by N-acetyltransferase 2 (NAT2); however, investigations of NAT2-mediated drug interaction...

Descripción completa

Detalles Bibliográficos
Autores principales:	Park, Yeo-Dim, Chae, Yoon-Jee, Maeng, Han-Joo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10221159/ https://www.ncbi.nlm.nih.gov/pubmed/37242713 http://dx.doi.org/10.3390/pharmaceutics15051471

Ejemplares similares

Amifampridine for Lambert-Eaton myasthenic syndrome
Publicado: (2022)

Genetic variation in aryl N-acetyltransferase results in significant differences in the pharmacokinetic and safety profiles of amifampridine (3,4-diaminopyridine) phosphate
por: Haroldsen, Peter E, et al.
Publicado: (2015)

New Charge Transfer Complexes of K(+)-Channel-Blocker Drug (Amifampridine; AMFP) for Sensitive Detection; Solution Investigations and DFT Studies
por: Alghanmi, Reem M., et al.
Publicado: (2021)

Update on treatment options for Lambert–Eaton myasthenic syndrome: focus on use of amifampridine
por: Lindquist, Sabine, et al.
Publicado: (2011)

Drug-drug interaction of acetaminophen and roxithromycin with the cocktail of cytochrome P450 and hepatotoxicity in rats
por: Liu, Xiang, et al.
Publicado: (2020)

Drug–drug interaction study of imatinib and voriconazole in vitro and in vivo
por: Lin, Qianmeng, et al.
Publicado: (2019)

Amifampridine Phosphate (Firdapse) Is Effective in a Confirmatory Phase 3 Clinical Trial in LEMS
por: Shieh, Perry, et al.
Publicado: (2019)

Findings on In Vitro Transporter-Mediated Drug Interactions and Their Follow-Up Actions for Labeling: Analysis of Drugs Approved by US FDA between 2017 and 2021
por: Lee, Kyeong-Ryoon, et al.
Publicado: (2022)

Pharmacokinetics and Drug–Drug Interaction of Ocedurenone (KBP-5074) in vitro and in vivo
por: Wang, Ping, et al.
Publicado: (2023)

In Vitro and In Vivo Assessment of Metabolic Drug Interaction Potential of Dutasteride with Ketoconazole
por: Seo, Seong-Wook, et al.
Publicado: (2019)

Cytochrome P450-Based Drug-Drug Interactions of Vonoprazan In Vitro and In Vivo
por: Wang, Yiran, et al.
Publicado: (2020)

Toxicokinetics of β-Amanitin in Mice and In Vitro Drug–Drug Interaction Potential
por: Bang, Young Yoon, et al.
Publicado: (2022)

In vivo and In vitro Drug Interactions Study of Glimepride with Atorvastatin and Rosuvastatin
por: Galani, VJ, et al.
Publicado: (2010)

A Mechanistic Framework for In Vitro–In Vivo Extrapolation of Liver Membrane Transporters: Prediction of Drug–Drug Interaction Between Rosuvastatin and Cyclosporine
por: Jamei, M., et al.
Publicado: (2013)

Assessments of CYP‑inhibition‑based drug–drug interaction between vonoprazan and poziotinib in vitro and in vivo
por: Zhou, Shan, et al.
Publicado: (2023)

In Vitro and In Vivo Models of CLL–T Cell Interactions: Implications for Drug Testing
por: Hoferkova, Eva, et al.
Publicado: (2022)

Clinical Evaluation of Acetaminophen–Galgeuntang Interaction Based on Population Approaches
por: Tran, Quyen Thi, et al.
Publicado: (2020)

Evaluation for Potential Drug–Drug Interaction of MT921 Using In Vitro Studies and Physiologically–Based Pharmacokinetic Models
por: Ryu, Hyo-jeong, et al.
Publicado: (2021)

Arylamine N-acetyltransferases: from drug metabolism and pharmacogenetics to drug discovery
por: Sim, E, et al.
Publicado: (2014)

CYP‐mediated drug–drug interactions with evacetrapib, an investigational CETP inhibitor: in vitro prediction and clinical outcome
por: Cannady, Ellen A., et al.
Publicado: (2015)

N-acetyltransferase 2 and bladder cancer: an overview and consideration of the evidence for gene–environment interaction
por: Green, J, et al.
Publicado: (2000)

Amifampridine safety and efficacy in spinal muscular atrophy ambulatory patients: a randomized, placebo-controlled, crossover phase 2 trial
por: Bonanno, Silvia, et al.
Publicado: (2022)

Investigating the Contribution of Drug-Metabolizing Enzymes in Drug-Drug Interactions of Dapivirine and Miconazole
por: Valicherla, Guru Raghavendra, et al.
Publicado: (2021)

Prospective Prediction of Dapaconazole Clinical Drug–Drug Interactions Using an In Vitro to In Vivo Extrapolation Equation and PBPK Modeling
por: Antunes, Natalícia de Jesus, et al.
Publicado: (2022)

Can Drug–Drug Interactions Be Predicted from In Vitro Studies?
por: Kremers, Pierre
Publicado: (2002)

Drug–Drug Interaction Potential of Darolutamide: In Vitro and Clinical Studies
por: Zurth, Christian, et al.
Publicado: (2019)

Results From Drug–Drug Interaction Studies In Vitro and In Vivo Investigating the Inhibitory Effect of Finerenone on the Drug Transporters BCRP, OATP1B1, and OATP1B3
por: Heinig, Roland, et al.
Publicado: (2022)

Extraction of Pharmacokinetic Evidence of Drug–Drug Interactions from the Literature
por: Kolchinsky, Artemy, et al.
Publicado: (2015)

Prediction of drug interaction between oral adsorbent AST-120 and concomitant drugs based on the in vitro dissolution and in vivo absorption behavior of the drugs
por: Koya, Yohei, et al.
Publicado: (2016)

Pharmacokinetic Drug–Drug Interactions and Herb–Drug Interactions
por: Choi, Min-Koo, et al.
Publicado: (2021)

Extracting drug-enzyme relation from literature as evidence for drug drug interaction
por: Zhang, Yaoyun, et al.
Publicado: (2016)

Physiologically-Based Pharmacokinetic Modeling for Drug-Drug Interactions of Procainamide and N-Acetylprocainamide with Cimetidine, an Inhibitor of rOCT2 and rMATE1, in Rats
por: Jeong, Yoo-Seong, et al.
Publicado: (2019)

Absence of Clinically Meaningful Drug-Drug Interactions with Rezafungin: Outcome of Investigations
por: Flanagan, Shawn, et al.
Publicado: (2023)

In Vitro Investigation of Binding Interactions between Albumin–Gliclazide Model and Typical Hypotensive Drugs
por: Zurawska-Plaksej, Ewa, et al.
Publicado: (2021)

In Vitro and In Vivo Models for the Investigation of Potential Drugs Against Schizophrenia
por: Koszła, Oliwia, et al.
Publicado: (2020)

The interaction of thermal tolerance with drug cytotoxicity in vitro.
por: Morgan, J. E., et al.
Publicado: (1979)

In Vitro Evaluation of the Potential for Drug Interactions by Salidroside
por: Kasprzyk, Philip G., et al.
Publicado: (2023)

Tepotinib Inhibits Several Drug Efflux Transporters and Biotransformation Enzymes: The Role in Drug-Drug Interactions and Targeting Cytostatic Resistance In Vitro and Ex Vivo
por: Vagiannis, Dimitrios, et al.
Publicado: (2021)

Predicting Drug-Target Interactions Using Drug-Drug Interactions
por: Kim, Shinhyuk, et al.
Publicado: (2013)

An Overview of the Evidence and Mechanisms of Herb–Drug Interactions
por: Fasinu, Pius S., et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_dvj9ri5bm475mc59qqv0fgbeg9